tirzepatide kidneys (Zepbound) showed improved kidney function in obese patients with both chronic kidney disease and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https can tirzepatide affect kidneys Insights

J.O'connorG

Fatigue is reported by some individuals, particularly during the first few weeks of therapy

Your provider connects the dotsmeds, lifestyle, and root causes

C., Tiuca, R

days 1 to 30): 3 mg orally once a day Dose escalation (days 31 to 60): 7 mg orally once a day Maintenance dose (day 61 and onward): If no additional glycemic control is needed: 7 mg orally once a day If additional glycemic control is needed: 14 mg orally once a day SUBCUTANEOUS: Ozempic Injection: Initial dose: 0.25 mg subcutaneously once a week for 4 weeks, then 0.5 mg subcutaneously once a week Maintenance dose: 0.5 to 2 mg subcutaneously once a week, based on glycemic control If additional glycemic control is needed after at least 4 weeks on the 0.5 mg dose: Increase to 1 mg subcutaneously once a week